Taking esketamine through the nose doesn't seem to make suicidal thoughts any better or worse in adults with severe depression that hasn't responded to other treatments, no matter when they checked.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses the phrase 'shows no significant association with,' which explicitly frames the relationship as a statistical link rather than a cause-and-effect or probabilistic outcome. This language avoids implying certainty or likelihood, focusing only on whether a measurable connection exists.
Context Details
Domain
medicine
Population
human
Subject
Intranasal esketamine
Action
shows no significant association with
Target
reduction in suicidality in adults with treatment-resistant major depressive disorder at any time point assessed
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
The study looked at whether a nasal spray called esketamine helps reduce suicidal thoughts in people with severe depression, and it found that it doesn’t — which matches exactly what the claim says.